Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kezar Life Sciences, Inc. KZR

Full chart Compare
Set alert

Price alert · KZR

All alert types
7.29 USD 0.00 (+0.00%)

At closeMay 11, 2026, 4:00 PM EDT

7.37 +0.08 +1.10%

After hours · May 11, 4:00 PM ET

7.29 Day range 7.29

52-week range unavailable

YTD
+15.90%
1 year
+72.75%

Financial health

Altman Z-Score

1.05 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.8×
FY 2016: -257×FY 2017: -273×FY 2018: -193×FY 2019: -24.3×FY 2020: -54.9×FY 2021: -161×FY 2022: -69.7×FY 2023: -6.8×FY 2024: -5.8×FY 2025: -0.8×
FY 2016 5y median -6.8× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 98.2×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.7×
FY 2016: -133×FY 2017: -90.0×FY 2018: 41.3×FY 2019: 9.8×FY 2020: 16.3×FY 2021: 44.8×FY 2022: 17.6×FY 2023: 3.7×FY 2024: 4.2×FY 2025: 0.7×
FY 2016 5y median 4.2× FY 2025
P/FCF -0.9×
FY 2016: -234×FY 2017: -272×FY 2018: -205×FY 2019: -25.1×FY 2020: -61.8×FY 2021: -206×FY 2022: -78.5×FY 2023: -8.2×FY 2024: -6.6×FY 2025: -0.9×
FY 2016 5y median -8.2× FY 2025
EV/EBITDA 0.5×
FY 2016: -260×FY 2017: -271×FY 2018: -199×FY 2019: -22.0×FY 2020: -56.7×FY 2021: -166×FY 2022: -71.5×FY 2023: -6.8×FY 2024: -5.7×FY 2025: 0.5×
FY 2016 5y median -6.8× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 95.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -112.5%
FY 2016: -0.4%FY 2017: -0.4%FY 2018: -0.5%FY 2019: -4.0%FY 2020: -1.6%FY 2021: -0.5%FY 2022: -1.3%FY 2023: -12.1%FY 2024: -15.2%FY 2025: -112.5%
FY 2016 5y median -12.1% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -1591.8%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -1455.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -80.0%
FY 2016: 51.6%FY 2017: 33.2%FY 2018: -21.3%FY 2019: -45.0%FY 2020: -29.6%FY 2021: -27.7%FY 2022: -25.3%FY 2023: -54.3%FY 2024: -71.6%FY 2025: -80.0%
FY 2016 5y median -54.3% FY 2025
ROIC -72.2%
FY 2016: -83.4%FY 2017: -16.6%FY 2018: -22.2%FY 2019: -44.2%FY 2020: -29.3%FY 2021: -25.9%FY 2022: -24.4%FY 2023: -54.0%FY 2024: -68.1%FY 2025: -72.2%
FY 2016 5y median -54.0% FY 2025
ROA -73.1%
FY 2016: -78.7%FY 2017: -15.7%FY 2018: -20.2%FY 2019: -39.2%FY 2020: -27.5%FY 2021: -25.1%FY 2022: -22.8%FY 2023: -46.0%FY 2024: -57.9%FY 2025: -73.1%
FY 2016 5y median -46.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 42.3%
FY 2016: 0.0%FY 2017: 2.7%FY 2018: -182.6%FY 2019: -53.6%FY 2020: -13.2%FY 2021: -27.1%FY 2022: -30.2%FY 2023: -56.6%FY 2024: 18.7%FY 2025: 42.3%
FY 2016 FY 2025
EPS (diluted) -566.1%
FY 2016: 0.0%FY 2017: 5.8%FY 2018: -87.7%FY 2019: -35.2%FY 2020: 42.4%FY 2021: -9.5%FY 2022: 2.9%FY 2023: -38.6%FY 2024: 17.9%FY 2025: -566.1%
FY 2016 FY 2025
Free Cash Flow 30.2%
FY 2016: 0.0%FY 2017: 14.1%FY 2018: -157.8%FY 2019: -39.1%FY 2020: -21.8%FY 2021: -15.1%FY 2022: -41.3%FY 2023: -38.1%FY 2024: 11.0%FY 2025: 30.2%
FY 2016 FY 2025

Financial Health

Current Ratio 11.5×
FY 2016: 16.1×FY 2017: 35.3×FY 2018: 32.9×FY 2019: 13.5×FY 2020: 22.5×FY 2021: 25.8×FY 2022: 26.0×FY 2023: 11.7×FY 2024: 6.8×FY 2025: 11.5×
FY 2016 5y median 11.7× FY 2025
Quick Ratio 11.5×
FY 2016: 16.1×FY 2017: 35.3×FY 2018: 32.9×FY 2019: 13.5×FY 2020: 22.5×FY 2021: 25.8×FY 2022: 26.0×FY 2023: 11.7×FY 2024: 6.8×FY 2025: 11.5×
FY 2016 5y median 11.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.4×
FY 2016: 1.1×FY 2017: 6.1×FY 2018: 1.1×FY 2019: 0.2×FY 2020: 0.4×FY 2021: 0.9×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.3×FY 2025: 1.4×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -344×FY 2022: -60.1×FY 2023: -71.9×FY 2024: -56.9×FY 2025: 0.0×
FY 2016 5y median -60.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31